What is the recommended dosage of Cyclopam (Cyclobenzaprine) when administered intramuscularly?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cyclopam Intramuscular Dosing

There is no established intramuscular formulation or dosing regimen for Cyclopam (dicyclomine/cyclobenzaprine combination) or cyclobenzaprine as a single agent, as these medications are only available and approved for oral administration.

Critical Clarification on Cyclopam

The term "Cyclopam" typically refers to a combination product containing dicyclomine (an anticholinergic/antispasmodic) and paracetamol (acetaminophen), commonly used in some countries for abdominal pain and cramping. This is not the same as cyclobenzaprine, which is a muscle relaxant used for skeletal muscle spasm.

Cyclobenzaprine: Oral Administration Only

Cyclobenzaprine is exclusively available as an oral medication and has no intramuscular formulation. The approved dosing regimens are:

  • Standard dose: 5 mg three times daily, which demonstrates equivalent efficacy to 10 mg three times daily with lower sedation rates 1
  • Alternative dose: 10 mg three times daily for patients requiring higher doses 1
  • Lower dose: 2.5 mg three times daily was not significantly more effective than placebo and is not recommended 1

Pharmacokinetic Considerations

  • Oral bioavailability is 0.55 with plasma clearance of 689 ml/min 2
  • Effective half-life is 18 hours with approximately fourfold accumulation at steady state 2
  • Elderly patients require dose reduction as steady-state concentrations are twice as high compared to younger patients 2
  • Patients with hepatic insufficiency also demonstrate up to twofold higher steady-state concentrations 2

Common Pitfalls to Avoid

  • Do not attempt intramuscular administration of oral cyclobenzaprine formulations, as there is no safety or efficacy data for this route
  • Sedation is the most common adverse effect, occurring in >30% of patients, likely mediated through noncompetitive antagonism of central histamine H1 receptors 3
  • The 5 mg three times daily regimen provides optimal balance between efficacy and tolerability compared to higher doses 1

Alternative Muscle Relaxants with IM Formulations

If intramuscular muscle relaxation is required, consider benzodiazepines such as:

  • Lorazepam IM: 0.05 mg/kg for acute muscle spasm (dose reduced in elderly) 4
  • Diazepam IV: For muscle relaxation when IV access available, though requires careful respiratory monitoring 5

References

Guideline

Intramuscular Lorazepam Dosing for Seizure Activity in Elderly Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

IV Diazepam Administration for Muscle Relaxation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.